NHS urged to offer single pill to all over-50s to prevent heart attacks and strokes
The NHS could prevent thousands more heart attacks and strokes every year by offering everyone in the UK aged 50...
adminph
Leqembi enters second consultation period following NICE draft guidance update
NICE convenes third committee meeting for additional appraisal consideration Eisai Europe Ltd. and Biogen Idec Ltd. announced that NICE will...
Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects
A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide - also known as Ozempic - in...
NHS patients receive UK-donated plasma medicines for first time in 30 years
Octapharma supports NHS in building resilient supply chain Octapharma has announced that, for the first time in almost 30 years,...
SECuRE trial pre-chemo participants experience PSA level drops
Cohort expansion phase commences with promising results The Safety Review Committee (SRC) has confirmed the end of the Dose Escalation...
Rotherham NHS Foundation Trust enhances patient engagement
Innovative digital transformation leads to significant improvements To reduce waiting lists and enhance patient communication, Rotherham NHS Foundation Trust has...
Future drugs may snap supply chain fueling breast cancer
Cancer cells have an insatiable appetite for energy as they multiply more rapidly than normal cells. Greedy cancer cells hijack...
Bas Vorsteveld
Kenvue appoints Bas Vorsteveld as Managing Director for Northern Europe Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe. He will oversee...
Researchers reveal key mechanism behind bacterial cancer therapy
A research team led by Prof. LIU Chenli from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of...
Centauri therapeutics selects first ABX-01 clinical candidate
Lead candidate for lung infections moves to human trials Centauri Therapeutics Limited has announced the selection of its first clinical...
Common malaria drug repurposed to fight cancer
Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at...
Professor Dr Uli Brödl
Grünenthal has appointed Professor Dr Uli Brödl as CSO Grünenthal has announced that Professor Dr Uli Brödl will assume the role of Chief Scientific Officer (CSO)...
Blood cancer patients face treatment access disparity
New research highlights NHS approval gap compared to other cancers Research from the Blood Cancer Alliance reveals a significant disparity...
